Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy https://t.co/oThKw3AlGG
792 followers
1,864 followers
Important study by super fellow, Dr. #MariyaRozenblit and the incredible @YaleCancer @SmilowCancer #BreastCancer group assessing the efficacy of everolimus exemestane is now out in @BioMedCentral! @KerinAdelsonMD @SMougalian
161,688 followers
RT @YaleCancer: A new study led by Dr. Lajos Pusztai, .@SMougalian, Dr. Mariya Rozenblit & @KerinAdelsonMD in @BioMedCentral assesses patte…
15,670 followers
A new study led by Dr. Lajos Pusztai, .@SMougalian, Dr. Mariya Rozenblit & @KerinAdelsonMD in @BioMedCentral assesses patterns of treatment with everolimus exemestane in advanced HR+ HER2- #breastcancer. @SmilowCancer @YaleMed @YNHH target="_blank" href="https://t.co/2k2h7x">https://t.co/2k2h7x